Biome Australia (ASX:BIO) ROCE % : -81.91% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biome Australia ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biome Australia's annualized ROCE % for the quarter that ended in Dec. 2023 was -81.91%.

Biome Australia ROCE % Historical Data

The historical data trend for Biome Australia's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Australia ROCE % Chart

Biome Australia Annual Data

Trend

Jun21

Jun22

Jun23

ROCE %

-52.60

-52.04

Biome Australia Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	-54.46	-51.62	-57.23	-51.88	-81.91

Biome Australia ROCE % Calculation

Biome Australia's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-2.985	/	( ( (8.251 - 1.351)	+	(7.559 - 2.986) )	/ 2 )
	=	-2.985	/	( (6.9	+	4.573)	/ 2 )
	=	-2.985	/	5.7365
	=	-52.04 %

Biome Australia's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-2.91	/	( ( (7.559 - 2.986)	+	(7.176 - 4.644) )	/ 2 )
	=	-2.91	/	( ( 4.573	+	2.532 )	/ 2 )
	=	-2.91	/	3.5525
	=	-81.91 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Biome Australia (ASX:BIO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biome Australia ROCE % Related Terms

Thank you for viewing the detailed overview of Biome Australia's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biome Australia (ASX:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biome Australia Ltd (ASX:BIO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

192-194 Johnston Street, Collingwood, VIC, AUS, 3066

Website

https://www.biomeaustralia.com

Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics; and AXP, a certified range of performance products for athletes. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners. Key revenue is derived from domestic sales.